Financial statements Pharma Apteki
Balance sheet data of PHARMA APTEKI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 094 338,58 | 2 208 792,73 | 2 631 672,96 | 2 748 896,45 | 2 830 156,35 | 2 992 786,93 |
| A. Fixed assets | 310 926,12 | 711 395,58 | 1 023 416,21 | 898 328,39 | 823 641,11 | 665 398,74 |
| B. Current assets | 1 783 412,46 | 1 497 397,15 | 1 608 256,75 | 1 850 568,06 | 2 006 515,24 | 2 327 388,19 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 094 338,58 | 2 208 792,73 | 2 631 672,96 | 2 748 896,45 | 2 830 156,35 | 2 992 786,93 |
| A. Equity | 82 160,46 | -60 071,32 | -194 868,63 | -266 858,22 | -199 927,50 | -201 489,13 |
| B. Liabilities and provisions for liabilities | 2 012 178,12 | 2 268 864,05 | 2 826 541,59 | 3 015 754,67 | 3 030 083,85 | 3 194 276,06 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 950 475,79 | 2 174 260,11 | 2 725 917,34 | 2 929 054,89 | 2 895 134,25 | 3 100 558,96 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.